Search research articles
Contact Us
Filters
Showing results (51-60 of 70) with videos related to
Page
of 7
Sort By:
Cancer Research
|
November 11, 1998
Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases
M A Chekmareva, M M Kadkhodaian, C M Hollowell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2005
A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors
A A Desai, R L Schilsky, A Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potential
Z Dubauskas, T P Beck, S J Chmura, et al.
Clinical Pharmacology and Therapeutics
|
February 28, 2013
Estimation of renal cell carcinoma treatment effects from disease progression modeling
M L Maitland, K Wu, M R Sharma, et al.
In Vivo (Athens, Greece)
|
May 12, 1998
Prostate cancer metastasis-suppressor genes: a current perspective
B A Yoshida, M A Chekmareva, J F Wharam, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2011
A phase I study of sirolimus and bevacizumab in patients with advanced malignancies
E E W Cohen, M R Sharma, L Janisch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2015
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model
R Chugh, K A Griffith, E J Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 7, 2019
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model
R Chugh, K A Griffith, E J Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 3, 1995
Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21
O I Olopade, H M Pomykala, F Hagos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 21, 2013
Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer
A J Armstrong, M Häggman, W M Stadler, et al.
Page
of 7
Search research articles
Search
Showing results (51-60 of 70) with videos related to
Sort By:
Page
of 7
Cancer Research
|
November 11, 1998
Chromosome 17-mediated dormancy of AT6.1 prostate cancer micrometastases
M A Chekmareva, M M Kadkhodaian, C M Hollowell, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 13, 2005
A phase I study of antisense oligonucleotide GTI-2040 given by continuous intravenous infusion in patients with advanced solid tumors
A A Desai, R L Schilsky, A Young, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
October 31, 1998
Activated calphostin C cytotoxicity is independent of p53 status and in vivo metastatic potential
Z Dubauskas, T P Beck, S J Chmura, et al.
Clinical Pharmacology and Therapeutics
|
February 28, 2013
Estimation of renal cell carcinoma treatment effects from disease progression modeling
M L Maitland, K Wu, M R Sharma, et al.
In Vivo (Athens, Greece)
|
May 12, 1998
Prostate cancer metastasis-suppressor genes: a current perspective
B A Yoshida, M A Chekmareva, J F Wharam, et al.
European Journal of Cancer (Oxford, England : 1990)
|
March 29, 2011
A phase I study of sirolimus and bevacizumab in patients with advanced malignancies
E E W Cohen, M R Sharma, L Janisch, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
April 11, 2015
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model
R Chugh, K A Griffith, E J Davis, et al.
Annals of Oncology : Official Journal of the European Society for Medical Oncology
|
February 7, 2019
Doxorubicin plus the IGF-1R antibody cixutumumab in soft tissue sarcoma: a phase I study using the TITE-CRM model
R Chugh, K A Griffith, E J Davis, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 3, 1995
Construction of a 2.8-megabase yeast artificial chromosome contig and cloning of the human methylthioadenosine phosphorylase gene from the tumor suppressor region on 9p21
O I Olopade, H M Pomykala, F Hagos, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
November 21, 2013
Long-term survival and biomarker correlates of tasquinimod efficacy in a multicenter randomized study of men with minimally symptomatic metastatic castration-resistant prostate cancer
A J Armstrong, M Häggman, W M Stadler, et al.
Page
of 7